AQUACEL® Ag Advantage
Bioburden is present in more than 78% of chronic wounds.1-2 You have the power to disrupt bioburden and advance healing with AQUACEL® Ag+ Extra.
The advantage of two technologies in one dressing to target bioburden and to advance healing.
MORE THAN SILVER™ was specifically developed to help antimicrobial silver (Ag+) work more effectively against complex microbial communities that may be associated with delayed healing and wound infection.
- Antimicrobial activity against CA-MRSA and prevention of biofilm reformation by AQUACEL™ Ag+ EXTRA dressing. Scientific Background Report. WHRI3875 MA239, 2013, Data on file, ConvaTec Inc.
- Malone M et al. 2017. The prevalence of bioburden in chronic wounds: a systemic review and meta-analysis of published data. JWC; 20-2
- Bowler PG, Parsons, D. Combatting wound biofilm and recalcitrance with a novel anti-biofilm Hydrofiber® wound dressing. Wound Medicine 14 (2016) 6-11
- Bowler PG, Welsby S, Towers V, Booth V, Hogarth A, Rowlands V, Joseph A, et al, 2012. Multidrug-resistant organisms, wounds and topical antimicrobial protection. Int Wound J. 9. 387-39631.
- Chen X, Stewart PS, 2000. Biofilm removal caused by chemical treatments. Wat. Res, 34: 4229-4233 37 Seth AK, Zhong A, Nguyen KT, Hong
- Banin E, Brady K.M. & Greenberg EP (2006). Chelator-Induced Dispersal and Killing of Pseudomonas aeruginosa Cells in Biofilm Appl. Environ. Microbiol. 72.2064-2069
- Barnea Y, Amir A, Leshem D, Zaretski A, Weiss J, Shafir R, et al, 2004, Clinical comparative study of AQUACEL® and paraffin gauze dressing for split-skin donor site treatment. Ann Plast Surg. 53; 132-36
- Kogan L, Moldavsky M, Svalb S, Govrin-Yehudain J, 2004, Comparative study of AQUACEL® and Silverol treatment in burns. Ann Burns Fire Disasters; 17; 201-207
- BrunnerU, Eberlein T, 2000. Experiences with hydrofibers in the most treatment of chronic wounds, in particular of diabetic foot. VASA; 29253-257
- Newman GR, Walker M, Hobot jA, Bowler PG, 2006. Visualization of bacterial sequestration and bacterial activity within hydrating Hydrofiber™ wound dressing. Biomaterials; 27:1129-1139
- Walker M, Hobot JA, Newman GR, Bowler PG, 2003. Scanning electron microscopic examination of bacterial immobilization in a carboxymethyl cellulose (AQUACEL®) and laginate dressing. Biomaterials 24; 883-890
- Bowler PG, Jones SA, Davies BJ, Coyle E, 1999. Infection control properties of some wound dressings. J. Wound Care; 8. 499-502
- Walker M. Bowler PG, Cochrane CA, 2007. In-vitro studies to show sequestration of matrix metalloproteinases by silver-containing wound care products. Ostomy/Wound Management 2007; 53:18-25
- Walker M and parsons D, 2010. Hydrofiber® Technology; its role in exudate management. Wounds UK; 6; 31-38
- Parsons D, Bowler PG, Myles V, Jones SA, 2005. Silver antimicrobial dressings in wound management; A comparison of antibacterial, physical and chemical characteristics. WOUNDS; 17; 222-232